Warning: The NCBI web site requires JavaScript to function. more...
A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
Zhou T, Han Y, Dang Y, Wang X, Zheng YH.
Retrovirology. 2009 Apr 3;6:31.
Related citations
Demonstration of a novel HIV-1 restriction phenotype from a human T cell line.
Han Y, Wang X, Dang Y, Zheng YH.
PLoS One. 2008 Jul 30;3(7):e2796.
APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
PLoS Pathog. 2008 Jul 4;4(7):e1000095.
Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS.
J Virol. 2011 Nov;85(21):11220-34. Epub 2011 Aug 10.
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
Yu Q, Chen D, König R, Mariani R, Unutmaz D, Landau NR.
J Biol Chem. 2004 Dec 17;279(51):53379-86. Epub 2004 Oct 4.
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA, Pathak VK.
J Virol. 2007 Aug;81(15):8201-10. Epub 2007 May 23.
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.
Dang Y, Wang X, Esselman WJ, Zheng YH.
J Virol. 2006 Nov;80(21):10522-33. Epub 2006 Aug 18. Erratum in: J Virol. 2011 May;85(10):5243.
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
Doehle BP, Schäfer A, Cullen BR.
Virology. 2005 Sep 1;339(2):281-8.
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
Wichroski MJ, Robb GB, Rana TM.
PLoS Pathog. 2006 May;2(5):e41. Epub 2006 May 12.
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
Wiegand HL, Doehle BP, Bogerd HP, Cullen BR.
EMBO J. 2004 Jun 16;23(12):2451-8. Epub 2004 May 20.
Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.
Mandal D, Exline CM, Feng Z, Stoltzfus CM.
J Virol. 2009 Jun;83(12):6067-78. Epub 2009 Apr 8.
Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
Nagao T, Yamashita T, Miyake A, Uchiyama T, Nomaguchi M, Adachi A.
J Med Invest. 2010 Feb;57(1-2):89-94.
Further investigation of simian immunodeficiency virus Vif function in human cells.
Gaddis NC, Sheehy AM, Ahmad KM, Swanson CM, Bishop KN, Beer BE, Marx PA, Gao F, Bibollet-Ruche F, Hahn BH, Malim MH.
J Virol. 2004 Nov;78(21):12041-6.
Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF.
J Virol. 2006 Mar;80(6):3112-5.
Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B, Sarkis PT, Luo K, Yu Y, Yu XF.
J Virol. 2005 Aug;79(15):9579-87.
Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins.
Virgen CA, Hatziioannou T.
J Virol. 2007 Dec;81(24):13932-7. Epub 2007 Oct 17.
Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.
PLoS One. 2008;3(12):e3963. Epub 2008 Dec 17.
Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity.
Vetter ML, Johnson ME, Antons AK, Unutmaz D, D'Aquila RT.
PLoS Pathog. 2009 Feb;5(2):e1000292. Epub 2009 Feb 6.
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.
Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K.
J Virol. 2003 Nov;77(21):11398-407.
Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z, Zhang W, Chen G, Xu R, Yu XF.
J Mol Biol. 2008 Sep 12;381(4):1000-11. Epub 2008 Jun 28.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on